Your browser doesn't support javascript.
loading
Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region.
Resta, Emanuela; Scioscia, Giulia; Lacedonia, Donato; Quarato, Carla Maria Irene; Panza, Francesco; Resta, Onofrio; Lepore, Giorgia; Buonamico, Enrico; Di Lecce, Valentina; Carpagnano, Giovanna Elisiana; Barbaro, Maria Pia Foschino; Rossi, Noemi.
Affiliation
  • Resta E; Translational Medicine and Health System Management, Department of Economy, University of Foggia, Foggia, Italy.
  • Scioscia G; Department of Medical and Surgical Sciences, Institute of Respiratory Diseases, Policlinico Universitario "Riuniti" di Foggia, University of Foggia, Foggia, Italy.
  • Lacedonia D; Department of Medical and Surgical Sciences, Institute of Respiratory Diseases, Policlinico Universitario "Riuniti" di Foggia, University of Foggia, Foggia, Italy.
  • Quarato CMI; Department of Medical and Surgical Sciences, Institute of Respiratory Diseases, Policlinico Universitario "Riuniti" di Foggia, University of Foggia, Foggia, Italy. carlamariairene.quarato@gmail.com.
  • Panza F; Population Health Unit, "Salus in Apulia Study", Research Hospital, National Institute of Gastroenterology "Saverio de Bellis", Castellana Grotte, Bari, Italy.
  • Resta O; Department of Basic Medical Sciences, Neuroscience and Sense Organs, Section of Respiratory Disease, University "Aldo Moro" of Bari, Bari, Italy.
  • Lepore G; Department of Medical and Surgical Sciences, Institute of Respiratory Diseases, Policlinico Universitario "Riuniti" di Foggia, University of Foggia, Foggia, Italy.
  • Buonamico E; Department of Basic Medical Sciences, Neuroscience and Sense Organs, Section of Respiratory Disease, University "Aldo Moro" of Bari, Bari, Italy.
  • Di Lecce V; Department of Basic Medical Sciences, Neuroscience and Sense Organs, Section of Respiratory Disease, University "Aldo Moro" of Bari, Bari, Italy.
  • Carpagnano GE; Department of Basic Medical Sciences, Neuroscience and Sense Organs, Section of Respiratory Disease, University "Aldo Moro" of Bari, Bari, Italy.
  • Barbaro MPF; Department of Medical and Surgical Sciences, Institute of Respiratory Diseases, Policlinico Universitario "Riuniti" di Foggia, University of Foggia, Foggia, Italy.
  • Rossi N; Department of Law, Economics and Human Sciences (DIGIES) "Mediterranea", University of Reggio Calabria, Reggio Calabria, Italy.
BMC Health Serv Res ; 22(1): 1283, 2022 Oct 25.
Article in En | MEDLINE | ID: mdl-36284319
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscarinic Antagonists / Pulmonary Disease, Chronic Obstructive Type of study: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Health Serv Res Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2022 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscarinic Antagonists / Pulmonary Disease, Chronic Obstructive Type of study: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Health Serv Res Journal subject: PESQUISA EM SERVICOS DE SAUDE Year: 2022 Type: Article Affiliation country: Italy